Skip to content

The Lone Star Bleeding Disorders Foundation is pleased to announce the Matthew Thomas Memorial Academic Scholarship Fund. 

To serve the bleeding disorders community of South Texas, the Lone Star BDF will award up to four $2,500 Academic Scholarships for the 2023-2024 school year.

 

To be eligible for the Matthew Thomas Memorial Academic Scholarship, students must be directly affected with an inherited bleeding disorder, or an immediate family member of someone with a bleeding disorder (parent/guardian/sibling/child of) and pursuing a degree from an accredited post-secondary University, College, or Junior College.  They do not have to be first-year students.  This scholarship is open to anyone pursuing a degree.

 

Along with a completed scholarship application, qualified applicants must provide documentation of post-secondary enrollment, high school/college transcripts, letters of recommendation, and personal essay.  A person may only receive a scholarship once.

 

Download PDF Application 

 

Matthew Thomas Memorial Academic Scholarship Checklist

Submit completed application and requested documents on our website www.lonestarbleedingdisorders.org under the Resources Tab by April 30th, 2023

You may also send printed application and documents, postmarked by April 30th, 2023 to

 

Lone Star Bleeding Disorders Foundation

ATTN:  Scholarship Committee

5600 Northwest Central Suite 140

Houston, TX 77092

 

Or email to Heidi Hensley

 

Be sure to include:
  •  
    • Completed Application
    • High-school or college transcripts
    • Documentation of post-secondary enrollment
    • Personal Essay
    • Two letters of recommendation

News from HFA

  • BioMarin Update: FDA Extends PDUFA Target Action Date to June 30, 2023

    SAN RAFAEL, Calif., March 6, 2023 — BioMarin Pharmaceutical Inc., a global biotechnology company dedicated to transforming lives through genetic discovery, announced that it received notice this afternoon from the U.S. Food and Drug Administration (FDA) that the agency has extended review of the company’s Biologics License Application (BLA) for ROCTAVIAN™ (valoctocogene roxaparvovec) gene therapy for adults The post BioMarin Update: FDA Extends PDUFA Target Action Date to June 30, 2023 appeared first on Hemophilia Federation of America.

  • The Complexity of Unwinding Medicaid

    The long-heralded Medicaid “unwinding” has begun. As previously reported, state Medicaid programs have, since the start of the COVID-19 pandemic, operated under a law that prohibited them from disenrolling Medicaid enrollees for the duration of the public health emergency (PHE). Congress changed that requirement in December 2022, delinking the Medicaid continuous enrollment obligation from the PHE. The post The Complexity of Unwinding Medicaid appeared first on Hemophilia Federation of America.

  • FDA Approves Sanofi’s Once-Weekly ALTUVIIIO™

    Source: Sanofi Press Release Sanofi announces that the U.S. Food and Drug Administration approved ALTUVIIIO™ [Antihemophilic Factor (Recombinant), Fc-vWF-XTEN Fusion Protein-ehtl], previously known as efanesoctocog alfa, a first-in-class, high-sustained factor VIII replacement therapy for adults and children with hemophilia A.  Sanofi states that with ALTUVIIIO, they are looking to raise the bar for people with The post FDA Approves Sanofi’s Once-Weekly ALTUVIIIO™ appeared first on Hemophilia Federation of America.

  • Dear Addy: Project CALLS

    Dear Addy,  I recently attended an event and learned about submitting issues with my insurance to HFA’s Project CALLS. I have an insurance issue, however, I still have some questions about how CALLS works and what happens when I submit an issue. Can you explain the process?  Signed,  CALLS Quandary   Dear Quandary,  You are not The post Dear Addy: Project CALLS appeared first on Hemophilia Federation of America.

  • Finding Strength Through Diversity

    This Black History Month, HFA asks our community to think back on the family members they’ve loved and the moments they created. We ask our community to think on the diversity of our community, the stories we’ve shared, and the people of color who helped make the bleeding disorder community as strong as it is The post Finding Strength Through Diversity appeared first on Hemophilia Federation of America.